✕
Login
Register
Back to News
Addex Therapeutics' Novel Gamma-Aminobutyric Acid Sub-Type B Receptor (GABAB) Positive Allosteric Modulator (PAM) Drug Candidate Demonstrates Baclofen-Like Efficacy In Non-Human Primate Chronic Cough Study
Benzinga Newsdesk
www.benzinga.com
Positive 93.8%
Neg 0%
Neu 0%
Pos 93.8%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment